MASCC oncodermatology clinical practice statement: prevention of acute radiation dermatitis using barrier-forming topical agents

MASCC Clinical Practice Statements (CPS) are practice-oriented resources designed to support clinicians by addressing areas of clinical need where high-quality evidence is limited. They reflect expert consensus on current practices, treatment approaches, and modalities commonly used in oncology care. This CPS aims to provide practical guidance for the prevention of acute radiation dermatitis (ARD) using barrier-forming topical agents.